Ferenc Jakab

Dr. Ferenc Jakab


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2020 in GeroScience
Verified
Journal Article
Open access
PDF file
GKGábor Kemenesi
Gábor Kemenesi
LKLászló Kornya
László Kornya
GTGábor Endre Tóth
Gábor Endre Tóth
KKKornélia Kurucz
Kornélia Kurucz
SZSafia Zeghbib
Safia Zeghbib
Ferenc JakabFerenc Jakab
Ferenc Jakab
The global impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is significant in terms of public health effects and its long-term socio-economic implications. Among all social groups, the elderly is by far the most affected age group regarding morbidity and mortality. In multiple countries spanning several continents, there are an increasing number of reports referencing the novel coronavirus disease-2019 (COVID-19) spread among nursing homes. These areas are now recognized as potent hotspots regarding the pandemic, which one considers with special regard. Herein, we present currently available data of fatal COVID-19 cases throughout Hungary, along with the analysis of the co-morbidity network. We also report on viral genomic data originating from a nursing home resident. The genomic data was used for viral haplotype network analysis. We emphasize the urgent need for public health authorities to focus on nursing homes and residential service units worldwide, especially in the care of the elderly and infirmed. Our results further emphasize the recent statement released by the World Health Organization (WHO) regarding the vulnerability among seniors and especially the high risk of COVID-19 emergence throughout nursing and social homes.

11 April 2021 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
ZLZsófia Lanszki
Zsófia Lanszki
BZBrigitta Zana
Brigitta Zana
SZSafia Zeghbib
Safia Zeghbib
Ferenc JakabFerenc Jakab
Ferenc Jakab
NSNikoletta Szabó
Nikoletta Szabó
GKGábor Kemenesi
Gábor Kemenesi
Canine distemper virus (CDV) is a major viral pathogen in domestic dogs, belonging to the Paramyxoviridae family, in the Morbillivirus genus. It is present worldwide, and a wide range of domestic animals and wild carnivores are at risk. In the absence of vaccination, dogs have a low chance of survival; however, if and when a dog survives, it can take an average of a few weeks to a few months to fully wipe out the virus. In the present study, we traced the course of infection of a 1-year-old mixed-breed male dog. The animal had an unusually long course of persistent CDV infection with a vector-borne heartworm (Dirofilaria immitis) co-infection. The dog excreted the CDV for 17 months with PCR positivity in urine samples collected from February 2019 through June 2020. The sequencing and phylogenetic analysis of the hemagglutinin gene revealed the CDV to be the member of the endemic Arctic-like genetic lineage. To the best of our knowledge, this report represents the longest documented canine infection of CDV. Notably, we highlight the necessity regarding CDV infectivity studies to better comprehend the transmission attributes of the virus.

4 November 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
MDMarianna Domán
Marianna Domán
Enikő FehérEnikő Fehér
Enikő Fehér
RVRenata Varga-Kugler
Renata Varga-Kugler
Ferenc JakabFerenc Jakab
Ferenc Jakab
Krisztian BanyaiKrisztian Banyai
Krisztian Banyai
Monkeypox is an emerging zoonotic disease with a growing prevalence outside of its endemic area, posing a significant threat to public health. Despite the epidemiological and field investigations of monkeypox, little is known about its maintenance in natural reservoirs, biological implications or disease management. African rodents are considered possible reservoirs, although many mammalian species have been naturally infected with the monkeypox virus (MPXV). The involvement of domestic livestock and pets in spillover events cannot be ruled out, which may facilitate secondary virus transmission to humans. Investigation of MPXV infection in putative reservoir species and non-human primates experimentally uncovered novel findings relevant to the course of pathogenesis, virulence factors and transmission of MPXV that provided valuable information for designing appropriate prevention measures and effective vaccines.

1 October 2019 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
FFFanni Földes
Fanni Földes
MMMónika Madai
Mónika Madai
VNViktória Németh
Viktória Németh
BZBrigitta Zana
Brigitta Zana
Henrietta PappHenrietta Papp
Henrietta Papp
Ferenc JakabFerenc Jakab
Ferenc Jakab

13 July 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GTGábor Tóth
Gábor Tóth
Adam HumeAdam Hume
Adam Hume
ESEllen L. Suder
Ellen L. Suder
SZSafia Zeghbib
Safia Zeghbib
ÁÁÁgota Ábrahám
Ágota Ábrahám
GKGábor Kemenesi
Gábor Kemenesi
Lloviu cuevavirus (LLOV) was the first identified member of Filoviridae family outside the Ebola and Marburgvirus genera. A massive die-off of Schreibers’s bats (Miniopterus schreibersii) in the Iberian Peninsula in 2002 led to its initial discovery. Recent studies with recombinant and wild-type LLOV isolates confirmed the zoonotic nature of the virus in vitro. We examined bat samples from Italy for the presence of LLOV in an area outside of the currently known distribution range of the virus. We detected one positive sample from 2020, sequenced the complete coding region of the viral genome and established an infectious isolate of the virus. In addition, we performed the first comprehensive evolutionary analysis of the virus, using the Spanish, Hungarian and the Italian sequences. The most important achievement of this study is the establishment of an additional infectious LLOV isolate from a bat sample using the SuBK12-08 cells, demonstrating that this cell line is highly susceptible to LLOV infection and confirming the previous observation that these bats are effective hosts of the virus in nature. This result further strengthens the role of bats as the natural hosts for zoonotic filoviruses.

1 May 2023 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
BBBálint Bencze
Bálint Bencze
VTViktória Temesfői
Viktória Temesfői
Sourav DasSourav Das
Sourav Das
Henrietta PappHenrietta Papp
Henrietta Papp
PKPéter Kaltenecker
Péter Kaltenecker
TKTamás Kőszegi
Tamás Kőszegi
Background: Parallel to the growth of the oral healthcare market, there is a constantly increasing demand for natural products as well. Many customers prefer products that contain fewer toxic agents, therefore providing an environmentally friendly solution with the benefit of smaller risk to the user. Medieval and early modern medicinal knowledge might be useful when looking for natural, herbal-based components to develop modern products. Along with these considerations we created, tested, and compared an entirely natural mouthwash, named Herba Dei. Methods: The manufacturing procedure was standardized, and the created tincture was evaluated by GC/MS analysis for active compounds, experimentally tested in cell-based cytotoxicity, salivary protein integrity, cell-free antioxidant activity, anti-bacterial and anti-viral assays, and compared with three market-leading mouthwashes. Results: Our tincture did not show significant damage in the cytotoxicity assays to keratinocyte and Vero E6 cells and did not disrupt the low molecular weight salivary proteins. Its radical scavenging capacity surpassed that of two tested, partly natural, and synthetic mouthwashes, while its antibacterial activity was comparable to the tested products, or higher in the bacterial aerobic respiratory assay. The active compounds responsible for the effects include naturally occurring phenylpropanoids, terpenes, and terpenoids. Our mouthwash proved to be effective in vitro in lowering the copy number of SARS-CoV-2 in circumstances mimicking the salivary environment. Conclusions: The developed product might be a useful tool to impede the transmission and spread of SARS-CoV-2 in interpersonal contact and aerosol-generating conditions. Our mouthwash can help reduce the oral bacterial flora and has an antioxidant activity that facilitates wound healing and prevents adverse effects of smoke in the oral cavity.